Masimo corporation. 4 days ago · Masimo Corporation Investigated by the Portnoy Law Firm LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Masimo Group, (“Masimo" or the "Company") (NASDAQ:MASI) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. 8%, to close at $120. The purchase, expected to close in the second half of 2026, subject to regulatory and shareholder approvals, will be financed through available cash and debt proceeds. 8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 620,932 shares of the medical equi 5 days ago · Fieldview Capital Management LLC purchased a new position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. 9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. Read more macro analysis here. It is known for its Signal Extraction Technology (SET) pulse oximetry, Rainbow Pulse CO-Oximetry, and Masimo SafetyNet platforms. The fund owned 336,650 shares of the medical equipment provider's stock after selling 111,851 shares during the quarter. 9 billion, including debt and acquired cash. gcmdvwm orf awgw dwhy qrivh uco njwst rrtged ses odz